Enliven Therapeutics (NASDAQ: ELVN) details planned stock sales via Jefferies

Rhea-AI Filing Summary

Enliven Therapeutics has filed a notice of proposed sale of common stock under Form 144, using Jefferies LLC as broker on NASDAQ. The filing lists multiple stock option positions in Enliven common stock, dated 08/09/2022, 02/23/2023, 02/13/2024, and 02/06/2025, each with specified amounts of common shares designated as securities to be sold.

Key Figures

Option-related shares dated 08/09/2022: 87373 shares Option-related shares dated 02/23/2023: 27567 shares Option-related shares dated 02/13/2024: 23364 shares +1 more

4 metrics

Option-related shares dated 08/09/2022 87373 shares Common stock underlying stock options referenced with date 08/09/2022

Option-related shares dated 02/23/2023 27567 shares Common stock underlying stock options referenced with date 02/23/2023

Option-related shares dated 02/13/2024 23364 shares Common stock underlying stock options referenced with date 02/13/2024

Option-related shares dated 02/06/2025 20491 shares Common stock underlying stock options referenced with date 02/06/2025

Key Terms

Form 144, Stock Options, Securities To Be Sold

3 terms

Form 144 regulatory

"144: Securities Information Common | Jefferies LLC..."

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Options financial

"Common | 08/09/2022 | Stock Options | Enliven Therapeutics"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

Securities To Be Sold regulatory

"144: Securities To Be Sold Common | 08/09/2022 | Stock Options"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/04/2026 - 04:39 PM Accepted by SEC EDGAR 08/04/2026 - 04:39 PM Learn about SEC filing dates

FAQ

What does the Form 144 filing by ELVN relate to?

The Form 144 relates to a proposed sale of Enliven Therapeutics common stock, with Jefferies LLC named as broker and NASDAQ indicated as the securities exchange for the potential transactions.

Which broker is listed in the ELVN Form 144 filing?

The broker listed is Jefferies LLC, located at 520 Madison Avenue, 4th Floor, New York, NY 10022, which is identified as handling the proposed sales of Enliven Therapeutics common stock.

What types of securities are mentioned in the ELVN Form 144?

The filing identifies common stock of Enliven Therapeutics, including shares underlying stock options granted on several historical dates, as the securities that may be sold under this notice.

Which option grant dates are referenced for ELVN in the Form 144?

The Form 144 references stock option positions dated 08/09/2022, 02/23/2023, 02/13/2024, and 02/06/2025, with each line specifying a number of Enliven Therapeutics common shares tied to that grant.

On which exchange are the ELVN shares in this Form 144 expected to trade?

The filing indicates NASDAQ as the securities exchange for the proposed sales of Enliven Therapeutics common stock covered by this Form 144 notice.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Jefferies LLC 520 Madison Avenue, 4th Floor New York NY 10022	158795	9216461.80	71000000	08/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/09/2022	Stock Options	Enliven Therapeutics			87373	08/09/2022	N/A
Common	02/23/2023	Stock Options	Enliven Therapeutics			27567	02/23/2023	N/A
Common	02/13/2024	Stock Options	Enliven Therapeutics			23364	02/13/2024	N/A
Common	02/06/2025	Stock Options	Enliven Therapeutics			20491	02/06/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)